Rudy Birsen Selected Research

COVID-19

10/2022

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rudy Birsen Research Topics

Disease

9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 09/2015
4	Lymphoma (Lymphomas) 08/2023 - 01/2018
4	Neoplasms (Cancer) 01/2023 - 09/2015
3	Leukemia 04/2024 - 01/2020
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2024 - 01/2022
2	Hemolysis 01/2023 - 10/2022
2	Hematologic Neoplasms (Hematological Malignancy) 10/2022 - 09/2022
1	Rheumatoid Arthritis 01/2024
1	Hodgkin Disease (Hodgkin's Disease) 08/2023
1	Hyperkalemia 08/2023
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2023
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2023
1	Thrombosis (Thrombus) 01/2023
1	COVID-19 10/2022
1	Glucosephosphate Dehydrogenase Deficiency 10/2022
1	Multiple Myeloma 09/2022
1	Oncogene Addiction 01/2022
1	Primary Effusion Lymphoma 01/2017
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2016
1	Hemorrhagic Cystitis 09/2016

Drug/Important Bio-Agent (IBA)

1	Biomarkers (Surrogate Marker)IBA 04/2024
1	Lenalidomide (CC 5013)FDA Link 01/2024
1	Azacitidine (5 Azacytidine)FDA Link 10/2023
1	Chimeric Antigen ReceptorsIBA 08/2023
1	Hemoglobins (Hemoglobin)IBA 08/2023
1	Immune Checkpoint InhibitorsIBA 08/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	fms-Like Tyrosine Kinase 3IBA 01/2023
1	eculizumab FDA Link 01/2023
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Complement Factor H (Factor H)IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	LipidsIBA 01/2023
1	Monoclonal AntibodiesIBA 10/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2022
1	rasburicase (Elitek)FDA Link 10/2022
1	Bortezomib (Velcade)FDA Link 09/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2022
1	eprenetapoptIBA 01/2022
1	trametinibIBA 01/2022
1	GSK621IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	AMP-Activated Protein KinasesIBA 11/2021
1	venetoclaxIBA 11/2021
1	1- ((2- ((2- chloropyridin- 4yl)amino)- 4'- (cyclopropylmethyl)- (4,5'- bipyrimidin)- 2'- yl)amino)- 2- methylpropan- 2- olIBA 10/2020
1	IronIBA 01/2020
1	alpha-hydroxyglutarateIBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Talc FDA Link 01/2017
1	ibrutinibIBA 12/2016
1	Glutamine (L-Glutamine)FDA Link 09/2015

Therapy/Procedure

2	Immunotherapy 08/2023 - 10/2022
2	Therapeutics 09/2022 - 01/2022
1	Neurosurgical Procedures 09/2022
1	Length of Stay 09/2022
1	Pleurodesis 01/2017
1	Hematopoietic Stem Cell Transplantation 09/2016